SecBot SecBot
SECBOTREPLAY Home › Report › MGNX

MGNX · MacroGenics completed the sale of its GMP manufacturing operations to…

MacroGenics, Inc. · PRESS-RELEASE filed Jul 2, 2026 at 09:25 ET

At the news

BULLISHIMPACT 6/10

PRESS-RELEASE filed Jul 2, 2026 at 09:25 ET

MacroGenics completed the sale of its GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million, transitioning to an asset-light R&D model and securing cash to fund its pipeline. The deal includes a supply agreement for continued production support.

  • Sale of GMP drug substance manufacturing operations to Bora Pharmaceuticals for $122.5 million
  • Approximately 140 employees transferred to Bora
  • Supply agreement signed for process development and production for MacroGenics' pipeline

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access